From: Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
Input parameters | Value | Source |
---|---|---|
One-year decision tree | ||
Ticagrelor | ||
No event | 0.894 | PLATO [7], Nikolic [8] |
Non-fatal MI | 0.050 | PLATO [7], Nikolic [8] |
Non-fatal stroke | 0.010 | PLATO [7], Nikolic [8] |
Death any cause | 0.046 | PLATO [7], Nikolic [8] |
Clopidogrel | ||
No event | 0.875 | PLATO [7], Nikolic [8] |
Non-fatal MI | 0.057 | PLATO [7], Nikolic [8] |
Non-fatal stroke | 0.009 | PLATO [7], Nikolic [8] |
Death any cause | 0.059 | PLATO [7], Nikolic [8] |
Markov model a | ||
Annual risk of MI in the no event state | 0.019 | PLATO [7], Nikolic [8] |
Annual risk of stroke in the no event state | 0.003 | PLATO [7], Nikolic [8] |
Risk of death in no event stateb | 2.000 | Thai Life table [10], Allen [11], Taneja [12] |
Risk of death in the non-fatal MI stateb | 6.000 | PLATO [7], Nikolic [8] |
Risk of death in the post MI stateb | 3.000 | PLATO [7], Nikolic [8] |
Risk of death in the non-fatal stroke stateb | 7.430 | Dennis [13], Hanke [14] |
Risk of death in the post stroke stateb | 3.000 | PLATO [7], Nikolic [8] |